Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
BNTC Price Targets and Analyst Ratings NASDAQ:BNTC
Historical Ratings and Targets
| Date | Upside / Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 2022-02-17 | 762.07% | HC Wainwright & Co. | $10.00 | Initiates Coverage On | Buy |
| 2020-10-05 | - | Ladenburg Thalmann | - | Downgrades | Buy Neutral |
BNTC Stock Trend
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.
Given the current short-term trend, the stock is expected to fall -48.46% during the next 3 months and, with a 90% probability hold a price between $0.32 and $0.76 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.
Data
| Date | Bottom | Mid | Top |
|---|---|---|---|
| 2022-07-05 | $0.61 | $1.03 | $1.45 |
| 2022-07-06 | $0.58 | $1.01 | $1.43 |
| 2022-07-07 | $0.56 | $0.98 | $1.41 |
| 2022-07-08 | $0.54 | $0.96 | $1.38 |
| 2022-07-11 | $0.52 | $0.94 | $1.36 |
| 2022-07-12 | $0.49 | $0.92 | $1.34 |
| 2022-07-13 | $0.47 | $0.89 | $1.32 |
| 2022-07-14 | $0.45 | $0.87 | $1.29 |
| 2022-07-15 | $0.43 | $0.85 | $1.27 |
| 2022-07-18 | $0.40 | $0.83 | $1.25 |
| 2022-07-19 | $0.38 | $0.80 | $1.23 |
| 2022-07-20 | $0.36 | $0.78 | $1.20 |
| 2022-07-21 | $0.34 | $0.76 | $1.18 |
| 2022-07-22 | $0.32 | $0.74 | $1.16 |
| 2022-07-25 | $0.29 | $0.72 | $1.14 |
| 2022-07-26 | $0.27 | $0.69 | $1.12 |
| 2022-07-27 | $0.25 | $0.67 | $1.09 |
| 2022-07-28 | $0.23 | $0.65 | $1.07 |
| 2022-07-29 | $0.20 | $0.63 | $1.05 |
| 2022-08-01 | $0.18 | $0.60 | $1.03 |
| 2022-08-02 | $0.16 | $0.58 | $1.00 |
| 2022-08-03 | $0.14 | $0.56 | $0.98 |
| 2022-08-04 | $0.11 | $0.54 | $0.96 |
| 2022-08-05 | $0.0922 | $0.51 | $0.94 |
| 2022-08-08 | $0.0699 | $0.49 | $0.91 |
| 2022-08-09 | $0.0476 | $0.47 | $0.89 |
| 2022-08-10 | $0.0252 | $0.45 | $0.87 |
| 2022-08-11 | $0.0029 | $0.43 | $0.85 |
| 2022-08-12 | $-0.0195 | $0.40 | $0.83 |
| 2022-08-15 | $-0.0418 | $0.38 | $0.80 |
Benitec Biopharma Limited, a biotechnology company, develops treatments for chronic and life-threatening human diseases based on its gene silencing technology, DNA-directed RNA interference (ddRNAi) in Australia. Its in-house development programs include TT-034, which is in Phase I/IIa clinical trials for the treatment of hepatitis C; Hepbarna for the treatment of the hepatitis B virus; Tribetarna for treating drug resistant non-small cell lung c... ![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
